China Pharma Holdings, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $45.4M
Liabilities Breakdown FY2018
Total Liabilities: $15.2M
Asset Breakdown
Total Assets: $45.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.2M | 2.6% |
| Accounts Receivable | $916.9K | 2.0% |
| Inventory | $5.1M | 11.1% |
| Property, Plant & Equipment | $19.3M | 42.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $266.4K | 0.6% |
| Other Assets | $18.7M | 41.1% |
Liabilities Breakdown
Total Liabilities: $15.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 7.0% |
| Long-Term Debt | $6.5M | 43.1% |
| Other Liabilities | $7.6M | 49.9% |